Dongkuk Pharmaceutical Co., the world's largest pharmaceutical and bio industry exhibition, operates a solo booth for 4 consecutive years at CPHI Worldwide 2025
Nov 06, 2025
|
'CPHI Worldwide' is a representative event in the pharmaceutical bio industry held annually in major European countries, and more than 2,400 pharmaceutical and bio companies and more than 62,000 industry officials from 160 countries around the world participated in the event.
Dongkuk Pharmaceutical, which has participated in the 'CPHI Worldwide' for four consecutive years since 2022 and has operated a solo booth, has focused on the technological excellence of its long-term injections (Depot) products, 'Lorelin Depot' and 'OctrinLar', which apply its Microsphere technology. In addition, it highlighted excellent efficacy and safety data based on the results of phase 3 clinical trials of the improved new drug, prostate hypertrophy drug 'Euresco tablet (dutasteride + tadarafil combination)', and emphasized the product's differentiation and market competitiveness to global buyers.
As a result, more than 300 existing customers and new buyers visited the Dongguk Pharmaceutical booth, and a number of new consultations related to Euroscojeong were also conducted.
A representative from Dongkuk Pharmaceutical said "In this 'CPHI Worldwide 2025', global pharmaceutical companies showed great interest in their microsphere technology and product portfolio."Through this event, we have materialized the strengthening of global partnerships and business expansion, and we will continue to expand our network and strengthen our global competitiveness."
This article was translated by Naver AI translator.
